In line with this, our study demonstrates that ColXVIII was coexpressed and formed a complex with ErbB receptors and α6-integrin in BC cells, thus having the potential to facilitate MAPK/ERK and PI3K/AKT signaling and tumor cell proliferation and migration (Figure 7 and Figure 3, G–J). The gene discussed is AKT1; the disease is breast cancer.